{"id":"https://genegraph.clinicalgenome.org/r/f6e1f36e-e9e4-40b3-80a7-56866052644fv1.0","type":"EvidenceStrengthAssertion","dc:description":"***COG2*** was first reported in relation to autosomal recessive Congenital Disorders of Glycosylation by Kodera H et al. in 2015 (PMID: 24784932). ***COG2*** has only been reported in one additional proband since the first publication. Mutations in ***COG2*** can lead to Congenital disorder of glycosylation (CDG), type IIq. CDGs result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor delay, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Clinical features of CDG-II caused by ***COG2*** are characterized by normal presentation at birth, followed by progressive deterioration with postnatal microcephaly, developmental delay, intellectual disability, seizures, spastic quadriplegia, liver dysfunction, hypocupremia and hypoceruloplasminemia in the first year of life. No supporting segregation information is available, and the disease mechanism appears to be biallelic loss of function. Heterozygous carriers are reportedly unaffected. This gene-disease relationship is supported by the biochemical function of ***COG2***, the protein encoded by this gene is one of eight proteins (Cog1-8) that form a Golgi-localized complex (COG) required for normal Golgi morphology and function. LDLC CHO cells have shown the effects of **COG2** and its restoration capabilities when transfected in the CHO cells (PMID: 21047787, 7962052). Coimmunoprecipitation experiments showed interaction with other proteins in the COG complex, specifically its interaction with ***COG1***, ***COG3***, and ***COG5***(PMID: 11980916). Although additional genetic and experimental evidence is needed to establish a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. A classification of LIMITED was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on 2/7/24 (SOP Version 10)\n\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f6e1f36e-e9e4-40b3-80a7-56866052644f","GCISnapshot":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-02-08T13:38:52.717Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10135","date":"2024-02-07T17:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64e55bf5-aaa4-48f6-ab91-08c87261a56d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a09d6bc-4b93-4e6e-a0e5-376feb1bbe48","type":"Finding","dc:description":"The conserved oligomeric Golgi (COG) complex is involved in intra-Golgi retrograde trafficking, and mutations in six of its eight subunits have been reported in congenital disorders of glycosylation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7962052","rdfs:label":"LDL deficient CHO cells ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9e9a9a2b-df5c-4531-b9ea-1621d487ca46","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/553d7a26-9add-4e0e-85c7-0dc5a0c70946","type":"Finding","dc:description":"The study shows how in Cog2 null mutant ldlC cells, the content of sphingomyelin (SM) is reduced to âˆ¼25% of WT cells. Cog2 transfection was effective in restoring SMS1 localization to the Golgi (Fig. 5C) and also in restoring the SM synthesis level to nearly normal levels in ldlC cells metabolically labeled with [3H]palmitate (Fig 6)\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21047787","rdfs:label":"Cog2 null mutant ldlC cells","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/18b9fbf2-def9-4994-982e-57741ae54210","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/064d5842-5dbb-4cb3-be66-2b70153574e3","type":"Finding","dc:description":"The researchers employed coimmunoprecipitation, focusing on the COG proteins, namely Cog1, Cog2, Cog3, and Cog5. In their experiment, an antibody against Cog2 was used to pull out proteins from rat liver cells. The results demonstrated that all examined COG proteins (Cog1, Cog2, Cog3, and Cog5) co-precipitated together. Similarly, using an antibody against Cog1 in a sample from bovine brain cells yielded the same outcome. Furthermore, the researchers confirmed that Sec8, a protein from a different complex, did not co-precipitate with the COG proteins.\n\nThis experimental evidence supports the interaction among the COG proteins, specifically Cog1, Cog2, Cog3, and Cog5, as revealed by co-immunoprecipitation. (Default: 0.5 points)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11980916","rdfs:label":"Interaction of COG2 and other COGs","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/67d145eb-648f-4e00-b53f-9447d650cc3e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5cbb9634-31a5-4cce-a081-203db1a7a309_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd114296-bb8a-40de-b55c-30a46282ce50","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd114296-bb8a-40de-b55c-30a46282ce50_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24784932","allele":{"id":"https://genegraph.clinicalgenome.org/r/40b68399-97d5-48dd-bdb4-b8cc07bb42e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007357.3(COG2):c.1900T>G (p.Trp634Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA345198944"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4d0a8a3a-142b-44b9-aaed-caf8a4b12f6c","type":"EvidenceLine","calculatedScore":2.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d0a8a3a-142b-44b9-aaed-caf8a4b12f6c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Western blot","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4d0a8a3a-142b-44b9-aaed-caf8a4b12f6c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24784932","allele":{"id":"https://genegraph.clinicalgenome.org/r/2fe72ce5-a61c-4d8e-8d2b-9fca37e58eb4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007357.3(COG2):c.701dup (p.Tyr234Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645293933"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/5cbb9634-31a5-4cce-a081-203db1a7a309","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24784932","rdfs:label":"Patient ","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/2fe72ce5-a61c-4d8e-8d2b-9fca37e58eb4"},{"id":"https://genegraph.clinicalgenome.org/r/40b68399-97d5-48dd-bdb4-b8cc07bb42e6"}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000252","obo:HP_0002506","obo:HP_0011967","obo:HP_0010837","obo:HP_0001263","obo:HP_0001999","obo:HP_0033725","obo:HP_0003256","obo:HP_0001410","obo:HP_0001250","obo:HP_0012506","obo:HP_0001249","obo:HP_0002510"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4d0a8a3a-142b-44b9-aaed-caf8a4b12f6c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/fd114296-bb8a-40de-b55c-30a46282ce50_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.6},{"id":"https://genegraph.clinicalgenome.org/r/bb110ddf-cd22-4d5b-b90a-2ed23694c3e3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/067f7efc-86d1-4f9d-8ab9-2dfd22808a96","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/067f7efc-86d1-4f9d-8ab9-2dfd22808a96_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29878199","allele":{"id":"https://genegraph.clinicalgenome.org/r/7902b7fd-6a3f-40c5-8def-459368caa5fc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007357.3(COG2):c.380del (p.Lys127ArgfsTer5)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA529684816"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/241d3675-7e7d-41ba-8fa4-0c605b0f2784","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/241d3675-7e7d-41ba-8fa4-0c605b0f2784_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29878199","allele":{"id":"https://genegraph.clinicalgenome.org/r/536e37e4-d398-42ce-bd56-cf3fd25b47a3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_007357.3(COG2):c.389T>A (p.Val130Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1447407"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/bb110ddf-cd22-4d5b-b90a-2ed23694c3e3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29878199","rdfs:label":"p78","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7902b7fd-6a3f-40c5-8def-459368caa5fc"},{"id":"https://genegraph.clinicalgenome.org/r/536e37e4-d398-42ce-bd56-cf3fd25b47a3"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"apolipoprotein C-III deficiency.","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/067f7efc-86d1-4f9d-8ab9-2dfd22808a96_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/241d3675-7e7d-41ba-8fa4-0c605b0f2784_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":4.2}],"evidenceStrength":"Limited","sequence":7787,"specifiedBy":"GeneValidityCriteria10","strengthScore":5.7,"subject":{"id":"https://genegraph.clinicalgenome.org/r/e6l9ncOX8WI","type":"GeneValidityProposition","disease":"obo:MONDO_0054559","gene":"hgnc:6546","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_67d145eb-648f-4e00-b53f-9447d650cc3e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}